Major Influenza Pandemic Threat Is Now Preventable And Treatable With Canopus' Aerosol Statin Formulation

Canopus BioPharma Inc. (OTCPK: CBIA) announced it has commissioned a team of experts led by Dr. Akihiro Shimosaka, to assist with its plans for major collaborations to license, manufacture and distribute its H1N1 Swine flu statin antiviral. This team is currently in negotiations with the Office of Disease Control and Emergency Response, the CDC and the SFDA in China with a view to initiating large scale clinical trials and gaining marketing approval on behalf of Canopus BioPharma. Complete news at...

Risks In Heart Patients Reduced By Walking Often And Far

An exercise program that burns a lot of calories reduced cardiac risk factors better than standard cardiac rehabilitation in overweight coronary patients, researchers report in Circulation: Journal of the American Heart Association. "The higher-caloric exercise, consisting of almost daily long-distance walking, resulted in double the weight loss and a greater fat mass loss than standard cardiac rehabilitation exercise," said Philip A. Ades, M.D. More at...

Medtronic Announces San Antonio As Home Of New Diabetes Facility

Medtronic, Inc. (NYSE: MDT) announced that the company has chosen San Antonio, Texas, as the home of its new Diabetes Therapy Management and Education Center. Medtronic is expected to hire nearly 1,400 professionals during a five-year period to staff the new 150,000-square-foot facility. The announcement took place today at the Overlook at the Rim office building, the proposed site for the new center. More at...